ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
As previously disclosed, on October 28, 2021, Integra LifeSciences Holdings
Corporation (the "Company") announced the appointment of Jan D. De Witte to
serve as its President and Chief Executive Officer. In connection with his
appointment as President and Chief Executive Officer of the Company, the Board
of Directors of the Company (the "Board") also appointed Mr. De Witte as a
director of the Board effective in connection with the commencement of his
employment.
On December 1, 2021, Mr. De Witte commenced employment with the Company as its
President and Chief Executive Officer and was appointed as a director of the
Board, with his term as a director expiring at the Company's 2022 annual meeting
of stockholders.
In connection with the commencement of Mr. De Witte's employment as President
and Chief Executive Officer of the Company, Peter J. Arduini's
previously-announced resignation from his position as President and Chief
Executive Officer and a director of the Company became effective as of December
1, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses